Send to

Choose Destination
Prev Med Rep. 2015;2:436-439.

Communication practices about HPV testing among providers in Federally Qualified Health Centers.

Author information

Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, Atlanta, GA, USA.
Battelle, Health & Analytics, Seattle, WA, USA.



Little is known about the information providers share with patients when ordering a co-test, or combined human papillomavirus (HPV) and Papanicolaou (Pap) test, for cervical cancer screening. We assessed provider perceptions of such communication practices with female patients aged 30-60 years.


We analyzed data from 98 providers in 15 Federally Qualified Health Center clinics across Illinois (2009-2010).


About 70% of the providers reported that when ordering a co-test, they would usually or always communicate information about the HPV test to their patients, explain the test detects a sexually transmitted infection, and discuss how the test results may determine their next screening interval. Most (>85%) reported that they were comfortable discussing co-test results. Compared with concordant positive results (HPV positive/Pap positive), providers were more likely to perceive that discordant results (HPV positive/Pap negative) would be too complex for patients to understand (25% vs. 15%, p = 0.006), and make patients feel less assured that they were getting the best standard of care (67% vs. 88%, p < 0.001).


As HPV testing plays a more prominent role in cervical cancer screening, more attention should be given to communications between providers and patients about the benefits and harms of different screening options.


Cervical cancer screening; Co-test; Communication practices; Human papillomavirus

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center